… in monitoring of patients with metastatic melanoma receiving … melanoma and reported the
clinical significance of 5SCD [… repeated every other month with monitoring of 5SCD level in …

… of malignant melanoma and monitoring its treatment. [ 31 ] Other studies reported a significant
… were significantly reduced in stage IV melanoma patients who respond to chemotherapy, [ …

… Many studies have used colorimetric methods monitoring the production of dopachrome …
an increase in eumelanin synthesis as seen in human melanoma cells [102]. Conversely, …

Background and aims With the development of novel therapies for advanced malignant
melanoma (MM), biomarkers that can accurately reflect the progression of MM are needed. …

… 5-S-cysteinyldopa (5SCD) exhibits promising potential as a urinary and serum biomarker
for melanoma… Furthermore, it is noteworthy that the clinical implications stemming from this …

… more than thousand studies described malignant melanoma as the most frequent oral …
5-S-cysteinyldopa formation by tyrosinase activity and intracellular thiols in human melanoma …

… Following those efforts by Wick’s group, Fujita et al. reported that 5-S-cysteinyldopa (5SCD), …
few cancer-antigens and escape from host surveillance for neoplasms. One of the potential …

… , cerebrospinal fluid 5-S-cysteinyldopa levels declined and … , but it had little clinical
significance. Vonoprazan can be … We could monitor eight novel antiepileptics using an LC/MS …

… diagnosing and monitoring patients with melanoma during … has prognostic value in patients
with melanoma, and it might … the tumor burden in patients with melanoma was reported [13…

… Herein, we provide an overview of circulating and other minimally invasive biomarkers
for therapeutic monitoring of patients with melanoma. In particular, the use of nucleic acids, …